737 filings
Page 21 of 37
8-K
e2ggrlti 2bg
7 Nov 11
Adventrx Reports Third Quarter 2011 Financial Results
12:00am
8-K
9d6crr57sjlkzpph
26 Oct 11
Adventrx and Fda Reach Agreement on Pivotal Study for ANX-514
12:00am
8-K/A
t9z2 wypk3
25 Oct 11
Financial Statements and Exhibits
12:00am
424B3
w2fwzdn8s4axc1 rn2y
13 Oct 11
Prospectus supplement
12:00am
EFFECT
mmgz5ihivu31u11qj69
13 Oct 11
Notice of effectiveness
12:00am
CORRESP
q7t6 2fr4
12 Oct 11
Correspondence with SEC
12:00am
8-K
1c4bf 5ezjfnq6dv8n
30 Sep 11
Adventrx Announces Results of Fda Meeting to Discuss Exelbine Nda
12:00am
8-K
9lbc7y 2ky
10 Aug 11
Adventrx Receives Complete Response Letter for Exelbine Nda
12:00am
8-K
p7kwnuxh
8 Aug 11
Adventrx Reports Second Quarter 2011 Financial Results
12:00am
8-K
drktpbs
8 Jul 11
Departure of Directors or Certain Officers
12:00am
8-K
pe0 7zyy2g
29 Jun 11
Changes in Registrant's Certifying Accountant
12:00am
8-K
gym8ae06
23 Jun 11
Changes in Registrant's Certifying Accountant
12:00am
8-K
qn1uimmg2 hapc
16 Jun 11
Departure of Directors or Certain Officers
12:00am
S-8
wbey2u02ubnvpv rknw
16 Jun 11
Registration of securities for employees
12:00am
CORRESP
o8kb7k js6eolnwld5
14 Jun 11
Correspondence with SEC
12:00am
CT ORDER
xk1jad om
6 Jun 11
Confidential treatment order
12:00am
8-K/A
mnwz6
3 Jun 11
Financial Statements and Exhibits
12:00am